About clinical studies

The Food and Drug Administration (FDA) and Institutional Review Boards (IRBs) carefully review clinical studies under their authority and help ensure that participants’ rights are protected and that they are not exposed to any unnecessary risks. Carefully conducted clinical studies sponsored by the government or a private company are considered to be the standard way to look at new possible treatments.

The close medical attention required in this study may result in gaining new information about your health, and could provide benefits in terms of your general health and well-being. However, there is no guarantee or promise that you will receive any benefits from this study. Participants can decide to stop participating in the study at any time without affecting the medical care that they are entitled to for their disease. Participants should talk with their doctors about possible risks associated with participating in this study.

To learn more about participating in the Belong clinical study, click here.